GAITHERSBURG, Maryland (Reuters) - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children despite uncertainty about the risks of long-term use, U.S.

GAITHERSBURG, Md. — Pfizer Inc. should get American approval to market its Celebrex arthritis-pain pill for use in children because the benefits outweigh the risks, a Food and Drug Administration ...

NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

LOS ANGELES, Dec 15 (Reuters) - Pfizer Inc. > won U.S. approval on Friday to promote its Celebrex pain reliever for treating children age two and older who have rheumatoid arthritis, the Food and Drug ...

The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...

It’s been a painful 15 months both for people with arthritis and for the companies that make their painkilling drugs. The once high-flying anti-inflammatories known as cox-2 inhibitors nearly crashed ...

A new use for a common painkiller. A medication prescribed to treat pain appears to have the power to keep cancer at bay. Celebrex is an anti-inflammatory used to alleviate symptoms of arthritis, ...